ENT Partners Grows in the Midwest Through Strategic Acquisition
ENT Partners Expands Presence in the Midwest
ENT Partners, LLC, a prominent Physician Practice Management Company known for its expertise in Ear, Nose, Throat, Sleep Medicine, and Facial Plastics, is taking significant strides in enhancing its reach in the Midwest through the acquisition of ENT Specialists, Ltd. This well-established otolaryngology practice has been serving communities with high-quality care and advanced treatment options.
Growth Through Strategic Partnership
The acquisition of ENT Specialists, Ltd provides a fantastic opportunity for ENT Partners to reinforce its commitment to exceptional patient care. Dr. Andrew Schubkegel, who has led the practice as Medical Director for over 30 years, is known for his dedication to providing comprehensive ENT services. With this new partnership, the practice aims to broaden its range of offerings that include advanced treatments for sinus disorders, sleep apnea, and much more.
Enhanced Service Offerings for Patients
This collaboration also paves the way for the introduction of new services that cater to a wider variety of health needs. ENT Specialists, Ltd will now offer allergy treatments, audiology services, and in-office CT scans, ensuring patients have access to state-of-the-art care under one roof. Such expanded capabilities reflect ENT Partners’ commitment to providing holistic health solutions.
Welcoming New Talent
In addition to the strategic acquisition, ENT Partners is thrilled to welcome Dr. Cynthia Duck, MD, JD, a distinguished facial plastic and reconstructive surgeon. This fall, Dr. Duck will join Dr. Schubkegel and his team to provide general ENT care while also specializing in cosmetic and complex facial reconstruction. The addition of Dr. Duck's expertise further enriches the services offered by ENT Specialists, Ltd.
Strengthening Commitment to Quality Care
Dr. Schubkegel expressed his enthusiasm about the partnership, stating that joining ENT Partners allows for continued excellence in patient care while benefiting from a larger network and management resources. This transition promises to offer exciting new opportunities for both patients and staff, reinforcing the mission of personalized care delivered with compassion.
CEO's Vision for the Future
Jim Feinstein, the CEO of ENT Partners, shared insights on the significance of this acquisition. He welcomed Dr. Schubkegel and his dedicated team to their expanding family of practices. ENT Partners has been thriving in the Chicago market, showing remarkable growth and success in delivering high-quality management services. The addition of ENT Specialists, Ltd aligns perfectly with their vision of increasing access to premium ENT care across the Midwest.
Inspiring Growth and Collaboration
Feinstein noted that this partnership will not only enhance operational efficiencies but also create revenue-generating opportunities. The synergies with their sister practice, Suburban Otolaryngology, located in Berwyn, Illinois, further exemplify their commitment to collaborative care and innovation within the otolaryngology field.
Recent Developments
This acquisition marks ENT Partners’ third strategic move in 2025, following their previous successful integrations with Baltimore ENT and Currence Physician Solutions. These expansions showcase their proactive approach toward enhancing healthcare delivery and patient satisfaction.
About ENT Partners
ENT Partners remains dedicated to supporting physicians by providing comprehensive solutions that empower them to focus on delivering outstanding patient care. With a robust operational framework, they alleviate administrative burdens, allowing practices of varying sizes—from solo practitioners to large groups—to thrive. Currently, ENT Partner practices span across 24 locations in the Midwest and East Coast, emphasizing their commitment to accessible healthcare.
Frequently Asked Questions
What does the acquisition of ENT Specialists, Ltd mean for patients?
Patients will benefit from an expanded range of services, including advanced treatments for allergies and sleep disorders, among others.
Who is leading the new combined practice?
Dr. Andrew Schubkegel continues as Medical Director, now joined by Dr. Cynthia Duck, who will contribute her expertise in facial plastic and reconstructive surgery.
How does ENT Partners support its practices?
ENT Partners provides comprehensive management services that relieve administrative burdens and enhance operational efficiency, facilitating the delivery of high-quality care.
What is the vision of ENT Partners?
ENT Partners aims to expand access to top-tier ENT care while maintaining a patient-centered approach across the Midwest.
What other acquisitions has ENT Partners made recently?
This is the third acquisition in 2025, following successful integrations with Baltimore ENT and Currence Physician Solutions, reinforcing their growth strategy.
About The Author
Contact Hannah Lewis privately here. Or send an email with ATTN: Hannah Lewis as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.